申请人:AHMED Mahmood
公开号:US20100113796A1
公开(公告)日:2010-05-06
The invention relates to compounds of formula (I)
wherein
one of R
5
and R
6
is hydrogen or R
2
and the other is (a)
pharmaceutical compositions containing them and their use in the treatment of conditions or disorders which are mediated via the S1P1 receptor.
本发明涉及化合物的公式(I),其中R5和R6中的一个是氢或R2,另一个是(a)。还涉及含有这些化合物的药物组合物,以及它们在治疗通过S1P1受体介导的疾病或疾病方面的用途。